Knight Therapeutics Inc.
GUD.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 127.55M | 115.05M | 141.84M | 128.63M | 118.23M |
| Total Receivables | 76.24M | 69.34M | 70.56M | 74.38M | 78.85M |
| Inventory | 85.09M | 75.73M | 70.45M | 69.54M | 83.12M |
| Prepaid Expenses | 5.39M | 3.36M | 3.88M | 3.70M | 1.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 132.90K | 229.40K | 14.55M |
| Total Current Assets | 294.29M | 263.48M | 286.86M | 276.47M | 296.65M |
|
|
|||||
| Total Current Assets | 294.29M | 263.48M | 286.86M | 276.47M | 296.65M |
| Net Property, Plant & Equipment | 16.02M | 15.70M | 15.91M | 13.52M | 15.12M |
| Long-term Investments | 62.76M | 61.82M | 63.14M | 60.46M | 63.49M |
| Goodwill | 62.76M | 61.82M | 63.14M | 60.46M | 63.49M |
| Total Other Intangibles | 207.03M | 215.94M | 214.70M | 219.56M | 230.05M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.02M | 52.74M | 59.01M | 57.82M | 52.13M |
| Total Assets | 712.31M | 690.73M | 715.01M | 715.94M | 747.48M |
|
|
|||||
| Total Accounts Payable | 64.12M | 56.85M | 63.54M | 64.64M | 61.20M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 464.20K | 4.89M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.07M | 14.29M | 16.32M | 14.36M | 15.46M |
| Total Finance Division Other Current Liabilities | 7.27M | 6.18M | 6.17M | 6.88M | 3.53M |
| Total Other Current Liabilities | 7.27M | 6.18M | 6.17M | 6.88M | 3.53M |
| Total Current Liabilities | 87.46M | 77.32M | 86.02M | 86.34M | 85.07M |
|
|
|||||
| Total Current Liabilities | 87.46M | 77.32M | 86.02M | 86.34M | 85.07M |
| Long-Term Debt | 24.40M | 24.82M | 31.70M | 33.33M | 36.73M |
| Short-term Debt | -- | -- | -- | 464.20K | 4.89M |
| Capital Leases | 2.63M | 3.35M | 3.74M | 4.16M | 3.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.96M | 27.90M | 30.89M | 26.56M | 19.90M |
| Total Liabilities | 139.45M | 133.39M | 152.36M | 150.40M | 145.25M |
|
|
|||||
| Common Stock & APIC | 418.62M | 413.99M | 418.45M | 428.61M | 433.28M |
| Retained Earnings | 106.73M | 105.40M | 108.07M | 114.25M | 128.43M |
| Treasury Stock & Other | 47.52M | 37.95M | 36.12M | 22.68M | 40.51M |
| Total Common Equity | 572.86M | 557.34M | 562.65M | 565.54M | 602.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 572.86M | 557.34M | 562.65M | 565.54M | 602.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 572.86M | 557.34M | 562.65M | 565.54M | 602.23M |
|
|
|||||
